{"result": "(\"entity\"<|>CLINICS<|>ORGANIZATION<|>Clinics is a medical journal that published clinical data related to sporadic medullary thyroid carcinoma.)\n##\n(\"entity\"<|>AMERICAN JOURNAL OF SURGICAL PATHOLOGY<|>ORGANIZATION<|>The American Journal of Surgical Pathology is a medical journal that published a histopathologic study of sporadic versus familial medullary thyroid carcinoma.)\n##\n(\"entity\"<|>JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM<|>ORGANIZATION<|>The Journal of Clinical Endocrinology and Metabolism published research on biomarker-based risk stratification for medullary thyroid cancer.)\n##\n(\"entity\"<|>HEAD AND NECK<|>ORGANIZATION<|>Head and Neck is a medical journal that published findings on different outcomes in sporadic versus familial medullary thyroid cancer.)\n##\n(\"entity\"<|>Pellegriti et al.<|>PERSON<|>Pellegriti et al. conducted a study evaluating the outcomes of surgery in patients with medullary thyroid carcinoma.)\n##\n(\"relationship\"<|>CLINICS<|>MEDULLARY THYROID CARCINOMA<|>Clinics published clinical data on sporadic medullary thyroid carcinoma<|>6)\n##\n(\"relationship\"<|>AMERICAN JOURNAL OF SURGICAL PATHOLOGY<|>MEDULLARY THYROID CARCINOMA<|>The American Journal of Surgical Pathology published a study on sporadic versus familial medullary thyroid carcinoma<|>6)\n##\n(\"relationship\"<|>JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM<|>MEDULLARY THYROID CARCINOMA<|>The Journal of Clinical Endocrinology and Metabolism published research on risk stratification for medullary thyroid cancer<|>6)\n##\n(\"relationship\"<|>HEAD AND NECK<|>MEDULLARY THYROID CARCINOMA<|>Head and Neck published findings on outcomes in sporadic versus familial medullary thyroid cancer<|>6)\n##\n(\"relationship\"<|>Pellegriti et al.<|>MEDULLARY THYROID CARCINOMA<|>Pellegriti et al. evaluated surgical outcomes in patients with medullary thyroid carcinoma<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Evan DB, Gagel RF, et al. Revised American Thyroid Association Guidelines for the Management\n         Referencias:                                                                                                                                  of Medullary Thyroid Carcinoma. The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid.\n         • Correia-Deur JM, Toledo RA, Imazawa AT, Lourenço DM., Ezabella MC, Tavares MR, et al. Sporadic medullary thyroid carcinoma: clinical        2015;25(6):567-610.\n           data from a university hospital. Clinics. 2009;64(5):379-86.\n         • Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Haas OA, Vierhapper H, et al. Sporadic versus familial medullary thyroid microcarci-\n           noma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol. 2001;25:1245-51.\n         • Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab.  55  Tras el tratamiento quirúrgico correcto, es falso que:\n           2010;95:2655-63.\n         • Saltiki K, Simeakis G, Anagnostou E, Zapanti E, Anastasiou E, Alevizaki M. Different outcomes in sporadic versus familial medullary       A. Los niveles de calcitonina y antígeno carcinoembrionario son los marcadores de la\n           thyroid cáncer. Head Neck. 2019;41:154-61.\n         • Wells SA, Asa SL, Dralle H, Elisei R, Evan DB, Gagel RFet al. Revised American Thyroid Association Guidelines for the Management of           evolución del proceso.\n           Medullary Thyroid Carcinoma. The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid.\n           2015;25(6):567-610.                                                                                                                       B. En caso de persistencia/recurrencia tumoral se pueden plantear radioterapia externa,\n                                                                                                                                                         ablación por radiofrecuencia, embolización, para las metástasis o persistencia local.\n                                                                                                                                                     C. Según recomendaciones de la ATA, la administración de I-131 podría ser beneficiosa por\n     54  En qué casos requiere tratamiento preventivo a edades más tempranas el cáncer                                                                   efecto de vecindad.\n         medular tiroideo (CMT):                                                                                                                     D.  Fármacos de la familia de los inhibidores de la tirosina cinasa han demostrado que\n         A. En el CMT familiar.                                                                                                                          pueden ser eficaces en caso de respuesta parcial o control de crecimiento tumoral en\n         B. En el MEN2A.                                                                                                                                 situaciones de persistencia del carcinoma medular de tiroides.\n         C. En el MEN2B.\n         D.  Es igual en todos.                                                                                                                      COMENTARIO\n                                                                                                                                                     Para evaluar los resultados de la cirugía en un carcinoma medular de tiroides disponemos\n         COMENTARIO                                                                                                                                  de métodos de imagen, de los que el más importante es la ecografía cervical, y analíticos.\n                                                                                                                                                     Entre estos últimos los más importantes son la determinación de calcitonina (CT) y antíge-\n         Mutaciones en línea germinal del protooncogén RET dan origen a carcinomas medulares                                                         no carcinoembrionario (CEA).\n         familiares. Se han descrito múltiples mutaciones a nivel de diversos exones de este pro-                                                    Los niveles, indetectables o elevados, después de la cirugía inicial predicen la evolución\n         tooncogén. Cada una de las mutaciones tiene una expresión clínica diferente, con mayor o                                                    posterior de estos pacientes. En el estudio de Pellegriti et al., en el que valoran a 63 pa-\n         menor probabilidad de desarrollar feocromocitoma, hiperparatiroidismo o enfermedad de                                                       cientes operados de cáncermedular de tiroides con pruebas de imagen postoperatorias\n         Hirschsprung.                                                                                                                               normales, la CT postoperatoria fue indetectable en 35 casos y elevada en 28. En 15 casos\n         De la misma forma, distintas mutaciones originan carcinomas medulares con distintos gra-                                                    de los que quedaron con CT elevada se detectó recidiva durante el periodo de seguimiento,\n         dos de     agresividad,      que la actual guía de la ATA clasifica en 3 grados: riesgo moderado,                                           mientras que solo se detectó recidiva en tres de los que quedaron con CT indetectable.\n         riesgo alto y riesgo muy alto. En la categoría de riesgo muy alto se incluye el MEN2B, en                                                   No solo la presencia de CT detectable después de la cirugía inicial predice la evolución de\n         cuyo caso se recomienda tiroidectomía profiláctica precoz, durante el primer año, o incluso                                                 estos pacientes, sino que también lo hace la evolución en el tiempo de este parámetro.\n         en los primeros meses de vida.                                                                                                              Un tiempo corto de duplicación de los niveles de CT predice una mala evolución de estos\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the management of thyroid diseases, including medullary thyroid carcinoma.)\n##\n(\"entity\"<|>MEDULLARY THYROID CARCINOMA<|>EVENT<|>Medullary thyroid carcinoma is a type of cancer that originates from the parafollicular cells of the thyroid gland and is addressed in the guidelines provided by the American Thyroid Association.)\n##\n(\"entity\"<|>EVAN DB<|>PERSON<|>Evan DB is a contributor to the revised guidelines for the management of medullary thyroid carcinoma published by the American Thyroid Association.)\n##\n(\"entity\"<|>GAGEL RF<|>PERSON<|>Gagel RF is a contributor to the revised guidelines for the management of medullary thyroid carcinoma published by the American Thyroid Association.)\n##\n(\"entity\"<|>WELLS SA<|>PERSON<|>Wells SA is a contributor to the revised guidelines for the management of medullary thyroid carcinoma published by the American Thyroid Association.)\n##\n(\"entity\"<|>MEN2A<|>EVENT<|>MEN2A is a genetic condition associated with an increased risk of medullary thyroid carcinoma and is mentioned in the context of preventive treatment in the guidelines.)\n##\n(\"entity\"<|>MEN2B<|>EVENT<|>MEN2B is a genetic condition associated with a higher risk of aggressive medullary thyroid carcinoma and is referenced in the guidelines for early prophylactic thyroidectomy.)\n##\n(\"relationship\"<|>EVAN DB<|>AMERICAN THYROID ASSOCIATION<|>Evan DB is a contributor to the guidelines published by the American Thyroid Association regarding medullary thyroid carcinoma<|>8)\n##\n(\"relationship\"<|>GAGEL RF<|>AMERICAN THYROID ASSOCIATION<|>Gagel RF is a contributor to the guidelines published by the American Thyroid Association regarding medullary thyroid carcinoma<|>8)\n##\n(\"relationship\"<|>WELLS SA<|>AMERICAN THYROID ASSOCIATION<|>Wells SA is a contributor to the guidelines published by the American Thyroid Association regarding medullary thyroid carcinoma<|>8)\n##\n(\"relationship\"<|>MEDULLARY THYROID CARCINOMA<|>AMERICAN THYROID ASSOCIATION<|>The American Thyroid Association provides guidelines for the management of medullary thyroid carcinoma<|>9)\n##\n(\"relationship\"<|>MEN2A<|>MEDULLARY THYROID CARCINOMA<|>MEN2A is a genetic condition that increases the risk of developing medullary thyroid carcinoma, as discussed in the guidelines<|>7)\n##\n(\"relationship\"<|>MEN2B<|>MEDULLARY THYROID CARCINOMA<|>MEN2B is a genetic condition that is associated with a very high risk of aggressive medullary thyroid carcinoma, as mentioned in the guidelines<|>7)\n<|COMPLETE|>"}]}